Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Srinivas Kammanadiminti"'
Autor:
Srinivas Kammanadiminti, Jason Comer, Gabriel Meister, Trevor Carnelley, Derek Toth, Shantha Kodihalli
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283164 (2023)
To meet the requirements of the Animal Rule, the efficacy of monotherapy with ANTHRASIL® (Anthrax Immune Globulin Intravenous (Human)) for inhalational anthrax was evaluated in blinded studies using rabbit and nonhuman primate models. Animals in bot
Externí odkaz:
https://doaj.org/article/4bdb373448674b32b0edd178fbbe2830
Publikováno v:
Parasites & Vectors, Vol 11, Iss 1, Pp 1-8 (2018)
Abstract Background Lotilaner is a new member of the isoxazoline class for treatment of flea and tick infestations in cats. This laboratory study with lotilaner vanilla-yeast flavoured chewable tablets (CredelioTM, Elanco) investigated the safety in
Externí odkaz:
https://doaj.org/article/3fe4d8dd376c4238b779a7018293767d
Publikováno v:
Parasites & Vectors, Vol 10, Iss 1, Pp 1-6 (2017)
Abstract Background Lotilaner (Credelio™, Elanco) is a novel isoxazoline that provides rapid speed of flea and tick knockdown which is sustained for at least 1 month following oral administration to dogs. The safety of lotilaner flavoured chewable
Externí odkaz:
https://doaj.org/article/81793de9dd274c5181f8a59ac420a25f
Autor:
Srinivas Kammanadiminti, Ravi Kumar Patnaikuni, Jason Comer, Gabriel Meister, Chris Sinclair, Shantha Kodihalli
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e106393 (2014)
We have evaluated the therapeutic efficacy of AIGIV when given in combination with levofloxacin and the effective window of treatment to assess the added benefit provided by AIGIV over standard antibiotic treatment alone in a New Zealand white rabbit
Externí odkaz:
https://doaj.org/article/1e24f53f7353408b8f554f8dcd46960b
Autor:
Srinivas Kammanadiminti, Chris Sinclair, Ravi Kumar Patnaikuni, Gabriel T. Meister, Shantha Kodihalli, Jason E. Comer
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e106393 (2014)
PLoS ONE, Vol 9, Iss 9, p e106393 (2014)
Background We have evaluated the therapeutic efficacy of AIGIV when given in combination with levofloxacin and the effective window of treatment to assess the added benefit provided by AIGIV over standard antibiotic treatment alone in a New Zealand w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7a91e18800142946f0cc081be27cb7
https://pubmed.ncbi.nlm.nih.gov/25226075
https://pubmed.ncbi.nlm.nih.gov/25226075